EDEM2 Antibodies

Santa Cruz Biotechnology features a diverse variety of EDEM2 monoclonal antibodies for research in understanding EDEM2's role in cellular processes. EDEM2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). EDEM2, or ER degradation-enhancing alpha-mannosidase-like protein 2, plays a crucial role in the quality control of glycoproteins within the endoplasmic reticulum. By facilitating the degradation of misfolded glycoproteins, EDEM2 is essential for maintaining cellular homeostasis and preventing the accumulation of defective proteins. EDEM2's function is particularly significant in various diseases, where protein misfolding can lead to cellular dysfunction. Researchers can explore mechanisms of protein processing and degradation using advanced detection methods such as horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) conjugates. Understanding EDEM2's role in protein quality control provides valuable insights into potential therapeutic strategies for protein misfolding disorders. EDEM2 research continues to reveal new aspects of cellular protein regulation and quality control mechanisms. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of cellular health and disease mechanisms.